Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Loipa Medel"'
Autor:
Jenysbel de la C. Hernandez Reyes, Orestes Santos Morales, Laura Hernandez Moreno, Pedro Pablo Pino Alfonso, Elia Neninger Vinageras, Julia Lilliam Knigths Montalvo, Aliuska Aguilar Sosa, Amnely Gonzalez Morera, Patricia Lorenzo-Luaces Alvárez, Yadira Aguilar Venegas, Mayelin Troche Concepción, Loipa Medel Pérez, Yanela Santiesteban González, Lázara García Fernández, Lorena Regueiro Rodríguez, Amparo Macías Abrahan, Mayrel Labrada Mon, Kalet León Monzón, Danay Saavedra Hernández, Tania Crombet Ramos
Publikováno v:
Vaccines, Vol 12, Iss 8, p 833 (2024)
Background: EGFR has been suggested to contribute to COPD development and progression. Excessive ligand activation of the receptor leads to epithelial hyperproliferation and increased production of mucus, together with alterations in the primary cili
Externí odkaz:
https://doaj.org/article/f54899132f964f37ba644a2e570bf213
Autor:
Henrry Diaz, Jorge Jiménez, Aray Hernández, Leivis Valdés, Ariadna Martínez, Leonor Porto, Raity Hernández, Nadina Travieso, Julio Héctor Jova, Loipa Medel, Mayelin Troche, Annia Gorte, Delmis Batista, Ana Rosa Valls, Leticia Cabrera, Milagros Domeq, Leslie Pérez, Patricia Lorenzo-Luaces, Lizet Sánchez, Danay Saavedra, Mayra Ramos, Tania Crombet
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
EGFR signaling is an important regulator of SARS-CoV induced lung damage, inflammation and fibrosis. Nimotuzumab is a humanized anti-EGFR antibody registered for several cancer indications. An expanded access study was conducted to evaluate the safet
Externí odkaz:
https://doaj.org/article/448cc783b2114a2ca0706994779c5ed5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, Anselmo A Abdo Cuza, Yamilka Hernández Sánchez, Aylin Granado Rodríguez, Sarahy Sepúlveda Figueroa, Egda M Llanez Gregorich, Mery L Torres Lahera, Francisco Gómez Peire, Teresita Montero González, Yaneth Zamora González, Ana L Añé Kouri, Addys González Palomo, Mayelin Troche Concepción, Loipa Medel Pérez, Patricia Lorenzo Luaces-Alvarez, Daymys Estévez Iglesias, Danay Saavedra Hernández, Mayra Ramos Suzarte, Tania Crombet Ramos
Publikováno v:
Immunotherapy. 14:521-530
Background: Lung injury and STAT1 deficit induce EGFR overexpression in SARS-CoV-2 infection. Patients & methods: A phase I/II trial was done to evaluate the safety and preliminary effect of nimotuzumab, an anti-EGFR antibody, in COVID-19 patients. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbaacc7da1ccf6e6bcedb1b9b2fa625e
https://doi.org/10.2217/imt-2022-0027
https://doi.org/10.2217/imt-2022-0027
Autor:
Danay Saavedra, Ana L. Añé-Kourí, Egda M. Llanez Gregorich, Jilma Mena, Patricia Lorenzo-Luaces, Henrry Diaz Londres, Aray Hernández Martínez, Jorge Jiménez Armada, Yamilka Hernández Sánchez, Yaneth Zamora González, Mayelin Troche, Loipa Medel, Mayra Ramos, Tania Crombet
Publikováno v:
Immunology letters.
SARS-CoV-2 infection causes a range of clinical presentations and induces changes in both innate and adaptive branches of the immune system. Furthermore, direct viral action to the cells of the lung promotes over-expression of the epidermal growth fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11561d53cc146dadc2db854a07534838
https://pubmed.ncbi.nlm.nih.gov/36174772
https://pubmed.ncbi.nlm.nih.gov/36174772
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.